D
Inspire Medical Systems, Inc.
INSP
$162.16
$3.322.09%
D
Sell
3/10/2025Downgrade
Inspire Medical Systems, Inc. (INSP) was downgraded to D+ from C- on 3/10/2025 due to a decline in the total return index.
Inspire Medical Systems, Inc. (INSP) was downgraded to D+ from C- on 3/10/2025 due to a decline in the total return index.
C
Hold
2/11/2025Upgraded
Inspire Medical Systems, Inc. (INSP) was upgraded to C- from D+ on 2/11/2025 due to a noticeable increase in the efficiency index, total return index and growth index. EBIT increased 122.68% from $14.32M to $31.88M, net income increased 90.43% from $18.5M to $35.22M, and earnings per share increased from $0.6 to $1.1418.
Inspire Medical Systems, Inc. (INSP) was upgraded to C- from D+ on 2/11/2025 due to a noticeable increase in the efficiency index, total return index and growth index. EBIT increased 122.68% from $14.32M to $31.88M, net income increased 90.43% from $18.5M to $35.22M, and earnings per share increased from $0.6 to $1.1418.
D
Sell
8/8/2024Upgraded
Inspire Medical Systems, Inc. (INSP) was upgraded to D+ from E+ on 8/8/2024 due to a significant increase in the growth index, efficiency index and volatility index. Net income increased 197.88% from -$10.01M to $9.79M, earnings per share increased from -$0.3378 to $0.32, and EBIT increased 133.51% from -$15.22M to $5.1M.
Inspire Medical Systems, Inc. (INSP) was upgraded to D+ from E+ on 8/8/2024 due to a significant increase in the growth index, efficiency index and volatility index. Net income increased 197.88% from -$10.01M to $9.79M, earnings per share increased from -$0.3378 to $0.32, and EBIT increased 133.51% from -$15.22M to $5.1M.
E
Sell
7/25/2024Downgrade
Inspire Medical Systems, Inc. (INSP) was downgraded to E+ from D- on 7/25/2024 due to a significant decline in the growth index, volatility index and total return index. EBIT declined 263.69% from $9.3M to -$15.22M, earnings per share declined from $0.4882 to -$0.3378, and operating cash flow declined 48.69% from $17.27M to $8.86M.
Inspire Medical Systems, Inc. (INSP) was downgraded to E+ from D- on 7/25/2024 due to a significant decline in the growth index, volatility index and total return index. EBIT declined 263.69% from $9.3M to -$15.22M, earnings per share declined from $0.4882 to -$0.3378, and operating cash flow declined 48.69% from $17.27M to $8.86M.
D
Sell
3/6/2024Upgraded
Inspire Medical Systems, Inc. (INSP) was upgraded to D- from E+ on 3/6/2024 due to a large increase in the growth index and volatility index. Operating cash flow increased 374.63% from $3.64M to $17.27M, earnings per share increased from -$0.2908 to $0.4882, and EBIT increased 169.01% from -$13.47M to $9.3M.
Inspire Medical Systems, Inc. (INSP) was upgraded to D- from E+ on 3/6/2024 due to a large increase in the growth index and volatility index. Operating cash flow increased 374.63% from $3.64M to $17.27M, earnings per share increased from -$0.2908 to $0.4882, and EBIT increased 169.01% from -$13.47M to $9.3M.
E
Sell
10/9/2023Downgrade
Inspire Medical Systems, Inc. (INSP) was downgraded to E+ from D- on 10/9/2023 due to a significant decline in the total return index and volatility index.
Inspire Medical Systems, Inc. (INSP) was downgraded to E+ from D- on 10/9/2023 due to a significant decline in the total return index and volatility index.
D
Sell
3/14/2023Downgrade
Inspire Medical Systems, Inc. (INSP) was downgraded to D- from D on 03/14/2023.
Inspire Medical Systems, Inc. (INSP) was downgraded to D- from D on 03/14/2023.
D
Sell
2/13/2023Upgraded
Inspire Medical Systems, Inc. (INSP) was upgraded to D from D- on 2/13/2023 due to a large increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.6 to $0.1053, EBIT increased 98.05% from -$17.19M to -$335, and operating cash flow increased 75.14% from $11M to $19.27M.
Inspire Medical Systems, Inc. (INSP) was upgraded to D from D- on 2/13/2023 due to a large increase in the growth index, total return index and volatility index. Earnings per share increased from -$0.6 to $0.1053, EBIT increased 98.05% from -$17.19M to -$335, and operating cash flow increased 75.14% from $11M to $19.27M.
D
Sell
2/8/2023Downgrade
Inspire Medical Systems, Inc. (INSP) was downgraded to D- from D on 2/8/2023 due to a decline in the volatility index.
Inspire Medical Systems, Inc. (INSP) was downgraded to D- from D on 2/8/2023 due to a decline in the volatility index.
D
Sell
5/31/2022Upgraded
Inspire Medical Systems, Inc. (INSP) was upgraded to D from D- on 5/31/2022 due to an increase in the volatility index.
Inspire Medical Systems, Inc. (INSP) was upgraded to D from D- on 5/31/2022 due to an increase in the volatility index.
D
Sell
5/13/2022Downgrade
Inspire Medical Systems, Inc. (INSP) was downgraded to D- from D on 5/13/2022 due to a decline in the volatility index and total return index.
Inspire Medical Systems, Inc. (INSP) was downgraded to D- from D on 5/13/2022 due to a decline in the volatility index and total return index.
D
Sell
5/6/2022Downgrade
Inspire Medical Systems, Inc. (INSP) was downgraded to D from D+ on 5/6/2022 due to a significant decline in the growth index, volatility index and solvency index. Operating cash flow declined 1,836.78% from $734 to -$12.75M, EBIT declined 781.71% from -$1.82M to -$16.06M, and earnings per share declined from -$0.0873 to -$0.61.
Inspire Medical Systems, Inc. (INSP) was downgraded to D from D+ on 5/6/2022 due to a significant decline in the growth index, volatility index and solvency index. Operating cash flow declined 1,836.78% from $734 to -$12.75M, EBIT declined 781.71% from -$1.82M to -$16.06M, and earnings per share declined from -$0.0873 to -$0.61.
D
Sell
5/4/2022Upgraded
Inspire Medical Systems, Inc. (INSP) was upgraded to D+ from D- on 5/4/2022 due to an increase in the volatility index.
Inspire Medical Systems, Inc. (INSP) was upgraded to D+ from D- on 5/4/2022 due to an increase in the volatility index.
D
Sell
5/1/2022Downgrade
Inspire Medical Systems, Inc. (INSP) was downgraded to D- from D+ on 05/01/2022.
Inspire Medical Systems, Inc. (INSP) was downgraded to D- from D+ on 05/01/2022.
D
Sell
4/21/2022Upgraded
Inspire Medical Systems, Inc. (INSP) was upgraded to D+ from D- on 04/21/2022.
Inspire Medical Systems, Inc. (INSP) was upgraded to D+ from D- on 04/21/2022.
D
Sell
4/20/2022Downgrade
Inspire Medical Systems, Inc. (INSP) was downgraded to D- from D+ on 4/20/2022 due to a decline in the volatility index and valuation index.
Inspire Medical Systems, Inc. (INSP) was downgraded to D- from D+ on 4/20/2022 due to a decline in the volatility index and valuation index.
D
Sell
3/15/2022Upgraded
Inspire Medical Systems, Inc. (INSP) was upgraded to D+ from D on 3/15/2022 due to an increase in the volatility index, growth index and solvency index. Operating cash flow increased 317.16% from -$338 to $734, EBIT increased 81.41% from -$9.8M to -$1.82M, and earnings per share increased from -$0.379 to -$0.0873.
Inspire Medical Systems, Inc. (INSP) was upgraded to D+ from D on 3/15/2022 due to an increase in the volatility index, growth index and solvency index. Operating cash flow increased 317.16% from -$338 to $734, EBIT increased 81.41% from -$9.8M to -$1.82M, and earnings per share increased from -$0.379 to -$0.0873.
D
Sell
11/23/2021Upgraded
Inspire Medical Systems, Inc. (INSP) was upgraded to D from D- on 11/23/2021 due to an increase in the volatility index and total return index.
Inspire Medical Systems, Inc. (INSP) was upgraded to D from D- on 11/23/2021 due to an increase in the volatility index and total return index.
D
Sell
11/8/2021Downgrade
Inspire Medical Systems, Inc. (INSP) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index, solvency index and valuation index. The quick ratio declined from 9.56 to 7.05.
Inspire Medical Systems, Inc. (INSP) was downgraded to D- from D on 11/8/2021 due to a decline in the volatility index, solvency index and valuation index. The quick ratio declined from 9.56 to 7.05.
D
Sell
7/7/2021Downgrade
Inspire Medical Systems, Inc. (INSP) was downgraded to D from D+ on 7/7/2021 due to a noticeable decline in the total return index, growth index and volatility index. Operating cash flow declined 153.07% from -$4.11M to -$10.4M, EBIT declined 122.16% from -$7.06M to -$15.69M, and earnings per share declined from -$0.2773 to -$0.5974.
Inspire Medical Systems, Inc. (INSP) was downgraded to D from D+ on 7/7/2021 due to a noticeable decline in the total return index, growth index and volatility index. Operating cash flow declined 153.07% from -$4.11M to -$10.4M, EBIT declined 122.16% from -$7.06M to -$15.69M, and earnings per share declined from -$0.2773 to -$0.5974.
D
Sell
7/27/2020Upgraded
Inspire Medical Systems, Inc. (INSP) was upgraded to D+ from D on 7/27/2020 due to an increase in the total return index.
Inspire Medical Systems, Inc. (INSP) was upgraded to D+ from D on 7/27/2020 due to an increase in the total return index.
D
Sell
8/13/2019Downgrade
Inspire Medical Systems, Inc. (INSP) was downgraded to D from D+ on 8/13/2019 due to a decline in the efficiency index and total return index. Total capital declined 2.68% from $181.78M to $176.9M.
Inspire Medical Systems, Inc. (INSP) was downgraded to D from D+ on 8/13/2019 due to a decline in the efficiency index and total return index. Total capital declined 2.68% from $181.78M to $176.9M.
D
Sell
7/29/2019Upgraded
Inspire Medical Systems, Inc. (INSP) was upgraded to D+ from D on 7/29/2019 due to a large increase in the total return index, efficiency index and solvency index. The quick ratio increased from 17.47 to 23.52.
Inspire Medical Systems, Inc. (INSP) was upgraded to D+ from D on 7/29/2019 due to a large increase in the total return index, efficiency index and solvency index. The quick ratio increased from 17.47 to 23.52.
D
Sell
11/7/2018Upgraded
Inspire Medical Systems, Inc. (INSP) was upgraded to D from E on 11/7/2018 due to a large increase in the solvency index and growth index. Earnings per share increased from -$0.4324 to -$0.22, operating cash flow increased 42.08% from -$6.13M to -$3.55M, and the quick ratio increased from 13.75 to 16.57.
Inspire Medical Systems, Inc. (INSP) was upgraded to D from E on 11/7/2018 due to a large increase in the solvency index and growth index. Earnings per share increased from -$0.4324 to -$0.22, operating cash flow increased 42.08% from -$6.13M to -$3.55M, and the quick ratio increased from 13.75 to 16.57.
E
Sell
8/8/2018None
Inspire Medical Systems, Inc. (INSP) was downgraded to E from U on 08/08/2018.
Inspire Medical Systems, Inc. (INSP) was downgraded to E from U on 08/08/2018.
NYSE
03/14/2025 4:00PM Eastern
Quotes delayed
